FluoGuide secures a pipeline of uPAR targeting products
FluoGuide A/S (“FluoGuide”) is pleased to announce that it has signed an agreement with Rigshospitalet and University of Copenhagen securing exclusive rights to a product patent covering a range of uPAR-targeting molecules.The invention comes from research, led by Professor Andreas Kjær and funded by a Grand Solutions Grant from Innovation Fund Denmark of approx. MDKK 10.3 (approx. MSEK 15.2). FluoGuide is one of the consortium members in this grant. “I am happy to see that we are able to deliver tangible results from our Grand Solutions Grant from Innovation Fund Denmark” says professor